Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...

The Food and Drug Administration (FDA) has accepted the supplemental New Drug Application (sNDA) for decitabine/cedazuridine plus venetoclax to treat adults with newly diagnosed acute myeloid leukemia ...

There are molecular testing gaps in myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML) treatment, highlighting ...

Break Through Cancer, a Boston-based cancer research foundation, has launched a clinical trial to evaluate the feasibility of ...

Acute myeloid leukemia (AML) is a type of blood cancer.Learn about this cancer that forms in the bone and bone marrow. Treatments include medications and bone marrow transplant.

Panelists stress that timely and accurate diagnosis of KMT2A-rearranged acute myeloid leukemia (AML) is essential for personalized treatment planning, highlighting the need to overcome systemic delays ...

Acute myeloid leukemia (AML) is a cancer of the blood and bone marrow that largely affects older adults. Discover the causes, risk factors, how it’s classified, and more information like on ...

June marks AML Awareness Month. It is a time to understand acute myeloid leukaemia. AML is a blood cancer needing quick ...

Acute myeloid leukemia (AML) is one type of cancer of the bone marrow and blood. In people with AML, something goes wrong and the bone marrow makes abnormal white blood cells called myeloblasts — ...

Acute myeloid leukemia (AML) pushes your bone marrow to make large numbers of abnormal and underdeveloped blood cells called blast cells. These cells crowd out healthy mature red blood cells ...

Acute myeloid leukemia treatment will usually include chemotherapy. Other treatment options include radiation therapy, stem cell therapy, and others.

Acute monocytic leukemia (AML-M5): Cancer develops in cells that make monocytes, a white blood cell. Acute megakaryocytic leukemia (AMLK): Affects cells responsible for red blood cells or platelets.